Antiresus immunoglobulin for pregnant women has disappeared from pharmacies


An antiresus immunoglobulin of domestic and foreign production has disappeared from pharmacies in at least 75 regions. The drug is used to prevent rhesus conflict between mother and fetus.

Tread marks: there is a shortage of an unparalleled drug for cancer patients in the Russian Federation

How long will the mesna reserves last and when will the country have its own production?

For example, according to the aggregators of pharmacy chains, there is no medicine in Moscow, St. Petersburg, Moscow region, Leningrad, Pskov, Ryazan, Tver and Samara regions.

In addition, there is a shortage of this drug in medical institutions. For example, it is not available in the perinatal centers of St. Petersburg and some medical institutions in Moscow, doctors and patients told Izvestia.

In response to a request from Izvestia, the St. Petersburg Health Committee acknowledged that there has been a shortage of this drug in the city since the end of 2024.

"According to information from medical organizations that independently purchase the drug, there are currently problems with its purchase due to the lack of offers on the market. The drug is not supplied centrally," the agency's response says.

Nikolay Bespalov, RNC Development Director, noted that the situation with such medicines has been consistently negative since 2024.

The expert stressed that Russia is almost completely dependent on imports.

"The domestic manufacturer is the only one and covers the needs of the Russian healthcare system by only 7-8%," he said.

At the same time, Bespalov also noted that there is a shortage of hyperimmune plasma in the world, from which the drug is produced. According to him, because of this, the release and sales of the drug are quite limited.

Read more in the exclusive Izvestia article:

Retail losses: immunoglobulin for pregnant women disappeared from pharmacies